Lovshin, Julie A.
Cherney, David Z.
Article History
First Online: 22 December 2018
Competing interests
: J.A.L. has received consulting fees and/or speaking honorarium from Boehringer Ingelheim, Prometic, Intarcia Therapeutics, Inc., Novo Nordisk, Eli Lilly & Co, Merck and AstraZeneca, and has received operating grant support from Merck and Sanofi. D.Z.C. has received consulting fees and/or speaking honorarium from Janssen, Boehringer Ingelheim-Eli, Lilly, AstraZeneca, Merck, Sanofi and Prometic, and has received operating funds from Janssen, Boehringer Ingelheim-Eli, Lilly, AstraZeneca and Merck.